Myelodysplastic Syndromes

A brief digest about this topic

Your bone marrow is the spongy tissue inside some of your bones, such as your hip and thigh bones. It contains immature cells, called stem cells. The stem cells can develop into the red blood cells that carry oxygen through your body, the white blood cells that fight infections, and the platelets that help with blood clotting. If you have a myelodysplastic syndrome, the stem cells do not mature into healthy blood cells. This leaves less room for healthy cells, which can lead to infection, anemia, or easy bleeding.

Myelodysplastic syndromes often do not cause early symptoms and are sometimes found during a routine blood test. If you have symptoms, they may include

  • Shortness of breath
  • Weakness or feeling tired
  • Skin that is paler than usual
  • Easy bruising or bleeding
  • Pinpoint spots under the skin caused by bleeding
  • Fever or frequent infections

Myelodysplastic syndromes are rare. People at higher risk are over 60, have had chemotherapy or radiation therapy, or have been exposed to certain chemicals. Treatment options include transfusions, drug therapy, chemotherapy, and blood or bone marrow stem cell transplants.

NIH National Cancer Institute

Provided by: NIH - National Institute of Health

Links shared publicly online about this topic

Myelodysplastic Syndromes on #MDlinx

mdlinx.com — “Myelodysplastic Syndromes on #MDlinxView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on October 13, 2010 at 11:54 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Practical use of azacitidine in higher-risk myelodysplastic syndromes: An expert panel opinion: Leukemia ... http://bit.ly/cpE8Ez #medicine

2 years ago...

Oncology Article | Myelodysplastic Syndromes

mdlinx.com — “Evaluation of comorbidities at diagnosis predicts outcome in myelodysplastic syndrome patientsView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on February 15, 2011 at 10:35 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Evaluation of comorbidities at diagnosis predicts outcome in myelodysplastic syndrome patients: Leukem... http://bit.ly/gQlPF0 #oncology

1 year ago...

Oncology Article | Myelodysplastic Syndromes

mdlinx.com — “Japanese phase I/II study of azacitidine in patients with myelodysplastic syndromesView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on June 1, 2011 at 10:57 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Japanese phase I/II study of azacitidine in patients with myelodysplastic syndromes: Cancer Science http://bit.ly/khAzQX #oncology

12 months ago...

Oncology Article | Myelodysplastic Syndromes

mdlinx.com — “Myelodysplastic syndromes: 2011 update on diagnosis, risk-stratification, and managementView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on June 6, 2011 at 3:29 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Myelodysplastic syndromes: 2011 update on diagnosis, risk-stratification, and management: American Jou... http://bit.ly/kJe0JA #oncology

12 months ago...

Oncology Article | Myelodysplastic Syndrome

mdlinx.com — “Outcome of High-Risk Myelodysplastic Syndrome After Azacitidine Treatment FailureView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on July 28, 2011 at 12:03 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Outcome of High-Risk Myelodysplastic Syndrome After Azacitidine Treatment Failure: Journal of Clinical... http://bit.ly/pdnSl7 #oncology

10 months ago...

Myelodysplastic Syndrome (MDS)

fhcrc.org — “Hutchinson Center research related to Myelodysplastic Syndrome (MDS), Myelodysplasia information and risk of Myelodysplastic Syndrome. Hutchinson Center, Seattle, WAView full resource at fhcrc.org

  • View Related
  • Share

Most Recently Shared on July 27, 2010 at 4:19 pm By:

HutchinsonCtr Hutchinson Center Hospital and Research

New videos: Watch our experts share info for patients & families battling myelodysplastic syndrome & related diseases http://ow.ly/2hgJY

2 years ago...

Oncology Article | myelodysplastic syndromes

mdlinx.com — “Cardiac iron overload in transfusion-dependent patients with myelodysplastic syndromesView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on June 29, 2011 at 2:59 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Cardiac iron overload in transfusion-dependent patients with myelodysplastic syndromes: British Journa... http://bit.ly/k4nLMF #oncology

11 months ago...

Oncology Article | Myelodysplastic Syndromes

mdlinx.com — “Coalesced multicentric analysis of 2,351 patients with myelodysplastic syndromes indicates an underestimation of poor-risk cytogenetics of myelodysplastic syndromes in the international prognostic scoring systemView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on April 28, 2011 at 7:10 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Coalesced multicentric analysis of 2,351 patients with myelodysplastic syndromes indicates an underest... http://bit.ly/jMWRHt #oncology

1 year ago...

Oncology Article | myelodysplastic syndrome

mdlinx.com — “Reduced ribosomal protein gene dosage and p53 activation in low risk myelodysplastic syndromeView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on July 27, 2011 at 5:32 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Reduced ribosomal protein gene dosage and p53 activation in low risk myelodysplastic syndrome: Blood http://bit.ly/qsXZrx #oncology

10 months ago...

Oncology Article - Myelodysplastic Syndromes

mdlinx.com — “Prognostic factors of response and overall survival in 282 higher-risk myelodysplastic syndromes treated with azacitidineView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on October 28, 2010 at 9:49 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Prognostic factors of response and overall survival in 282 higher-risk myelodysplastic syndromes treated ... http://bit.ly/d7hh2e #oncology

2 years ago...

Oncology Article | Myelodysplastic Syndromes

mdlinx.com — “Outcomes after induction chemotherapy in patients with acute myeloid leukemia arising from myelodysplastic syndromeView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on November 30, 2010 at 1:12 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Outcomes after induction chemotherapy in patients with acute myeloid leukemia arising from myelodyspla... http://bit.ly/exZTcL #oncology

1 year ago...

Oncology Article | Myelodysplastic syndrome

mdlinx.com — “Increased serum hepcidin levels during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndromeView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on March 10, 2011 at 6:41 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Increased serum hepcidin levels during treatment with deferasirox in iron-overloaded patients with mye... http://bit.ly/hfAy4k #oncology

1 year ago...

Oncology Article | myelodysplastic syndrome

mdlinx.com — “A randomized study of 2 dose levels of intravenous clofarabine in the treatment of patients with higher-risk myelodysplastic syndromeView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on July 20, 2011 at 1:27 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

A randomized study of 2 dose levels of intravenous clofarabine in the treatment of patients with highe... http://bit.ly/qCtWjE #oncology

10 months ago...

Oncology Article | Myelodysplastic Syndromes

mdlinx.com — “Safety, pharmacokinetics, and immunomodulatory effects of lenalidomide in children and adolescents with relapsed/refractory solid tumors or myelodysplastic syndrome: A childrens oncology group phase I consortium reportView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on December 16, 2010 at 5:29 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Safety, pharmacokinetics, and immunomodulatory effects of lenalidomide in children and adolescents wit... http://bit.ly/ePhp3z #oncology

1 year ago...

Oncology Article | Myelodysplastic Syndromes

mdlinx.com — “Alemtuzumab Treatment of Intermediate-1 Myelodysplasia Patients Is Associated With Sustained Improvement in Blood Counts and Cytogenetic RemissionsView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on November 22, 2010 at 3:11 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Alemtuzumab Treatment of Intermediate-1 Myelodysplasia Patients Is Associated With Sustained Improveme... http://bit.ly/cTZaXW #oncology

2 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

  • MDLinx

    Sandeep Pulim MD

    Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry

    View Profile

  • MDLinx

    Sandeep Pulim MD

    Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry

    View Profile

  • MDLinx

    Sandeep Pulim MD

    Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390